An in-depth look to HWAIL PHARM. CO., LTD operating, investing, and financing activities

061250 free cash flow for Q2 24 is -9.33 B KRW. For 2023, 061250 free cash flow was 4.98 B KRW and operating cash flow was 7.02 B KRW.